Search Articles
NEWARK (CN) – Actavis Totowa repeatedly violated FDA standards at its drugmaking plaints in New Jersey, federal prosecutors say. They say the drugs were adulterated, and improperly made, processed, packed or stored at three plants, two in Totowa and one in Little Falls.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.